These results indicate that the interaction between Aβ and the CCL5/CCR5 axis not only perturbs immune homeostasis in the CNS but also modulates systemic immunity to promote pathologic processes in AD (summarized in Fig. 2). This evidence concerns the gene CCR5 and Alzheimer disease.